Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-19-001638
Filing Date
2019-01-04
Accepted
2019-01-04 08:06:19
Documents
1
Period of Report
2019-01-02

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3982
  Complete submission text file 0001209191-19-001638.txt   5322
Mailing Address 1 EVERTRUST PLAZA 13TH FLOOR JERSEY CITY NJ 07302-6548
Business Address 1 EVERTRUST PLAZA 13TH FLOOR JERSEY CITY NJ 07302-6548 201-884-5485
SCYNEXIS INC (Issuer) CIK: 0001178253 (see all company filings)

EIN.: 562181648 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address ONE EMBRACADERO CTR STE 2700 SAN FRANCISCO CA 94111
Business Address
HANHAM ANN (Reporting) CIK: 0001286338 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36365 | Film No.: 19508424